Recombinant multi-species CSNK2A2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CSNK2A2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the alpha', or alpha 2, catalytic subunit of the protein kinase enzyme, casein kinase 2 (CK2). Casein kinase 2 is a serine/threonine protein kinase that phosphorylates acidic proteins such as casein. It is involved in various cellular processes, including cell cycle control, apoptosis, and circadian rhythms. This heterotetrameric kinase includes two catalytic subunits, either alpha or alpha', and two regulatory beta subunits. The closely related gene paralog encoding the alpha, or alpha 1 subunit (CSNK2A1, Gene ID: 1457) is found on chromosome 20. An intronic variant in this gene (alpha 2) may be associated with leukocyte telomere length in a South Asian population. A related transcribed pseudogene is found on chromosome 11. [provided by RefSeq, Aug 2017]
The Alternative Names of target: 1110035J23Rik,CK II alpha',CK2,CK2A2,CK2alpha',CSNK2A1,CSNK2A2,Casein kinase II subunit alpha',Csnk2a2

Target products collectionGo to CSNK2A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T80526-Ag-1/ GM-Tg-hg-T80526-Ag-2 Human CSNK2A2 protein Human
GM-Tg-rg-T80526-Ag-1/ GM-Tg-rg-T80526-Ag-2 Rat CSNK2A2 protein Rat
GM-Tg-mg-T80526-Ag-1/ GM-Tg-mg-T80526-Ag-2 Mouse CSNK2A2 protein Mouse
GM-Tg-cynog-T80526-Ag-1/ GM-Tg-cynog-T80526-Ag-2 Cynomolgus/Rhesus macaque CSNK2A2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T80526-Ag-1/ GM-Tg-felg-T80526-Ag-2 Feline CSNK2A2 protein Feline
GM-Tg-cang-T80526-Ag-1/ GM-Tg-cang-T80526-Ag-2 Canine CSNK2A2 protein Canine
GM-Tg-bovg-T80526-Ag-1/ GM-Tg-bovg-T80526-Ag-2 Bovine CSNK2A2 protein Bovine
GM-Tg-equg-T80526-Ag-1/ GM-Tg-equg-T80526-Ag-2 Equine CSNK2A2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T80526-Ag-1/ GM-Tg-hg-T80526-Ag-2; GM-Tg-rg-T80526-Ag-1/ GM-Tg-rg-T80526-Ag-2;
GM-Tg-mg-T80526-Ag-1/ GM-Tg-mg-T80526-Ag-2; GM-Tg-cynog-T80526-Ag-1/ GM-Tg-cynog-T80526-Ag-2;
GM-Tg-felg-T80526-Ag-1/ GM-Tg-felg-T80526-Ag-2; GM-Tg-cang-T80526-Ag-1/ GM-Tg-cang-T80526-Ag-2;
GM-Tg-bovg-T80526-Ag-1/ GM-Tg-bovg-T80526-Ag-2; GM-Tg-equg-T80526-Ag-1/ GM-Tg-equg-T80526-Ag-2
Products Name CSNK2A2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CSNK2A2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CSNK2A2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.